Minerva Neurosciences NERV
NASDAQ NERV
$2.49 -0.14 (-5.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Minerva Neurosciences (NERV) Times Interest Earned (2014)

Updated

Minerva Neurosciences' Times Interest Earned came in at -10.22 for Q2 2014.

Analysis

Minerva Neurosciences (NERV) Times Interest Earned (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 28.50
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 10.28
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 7.27
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 5.68
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 12.87
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Minerva Neurosciences 121.62 Mn -126.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -10.22
API Access

Minerva Neurosciences Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=NERV&period=max&api_key=YOUR_API_KEY